{"id":"https://openalex.org/W4387979607","doi":"https://doi.org/10.1183/13993003.congress-2023.pa1853","title":"Development of a huPCLS platform to explore IL-33 biology and test novel therapies","display_name":"Development of a huPCLS platform to explore IL-33 biology and test novel therapies","publication_year":2023,"publication_date":"2023-09-09","ids":{"openalex":"https://openalex.org/W4387979607","doi":"https://doi.org/10.1183/13993003.congress-2023.pa1853"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2023.pa1853","doi":"https://doi.org/10.1183/13993003.congress-2023.pa1853","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2023.pa1853","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway cell biology and immunopathology","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042339263","display_name":"Katherine E. Stephenson","orcid":"https://orcid.org/0000-0002-4737-7492","observed_orcids":["https://orcid.org/0000-0002-4737-7492"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Katherine Stephenson","raw_affiliation_strings":["Bioscience Asthma & Skin immunity, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience Asthma & Skin immunity, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061218374","display_name":"Aoife Kelly","orcid":"https://orcid.org/0000-0002-8101-3422","observed_orcids":["https://orcid.org/0000-0002-8101-3422"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Aoife Kelly","raw_affiliation_strings":["Translational Science and Experimental Medicine, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Science and Experimental Medicine, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090566480","display_name":"Claire Hollins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Claire Hollins","raw_affiliation_strings":["Bioscience Asthma & Skin immunity, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience Asthma & Skin immunity, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062505563","display_name":"Sofia Koch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sofia Koch","raw_affiliation_strings":["Imaging & Data Analytics, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imaging & Data Analytics, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Tina Baker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tina Baker","raw_affiliation_strings":["Translational Science and Experimental Medicine, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Science and Experimental Medicine, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004429523","display_name":"Yoichiro Ohne","orcid":"https://orcid.org/0000-0001-9280-9912","observed_orcids":["https://orcid.org/0000-0001-9280-9912"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yoichiro Ohne","raw_affiliation_strings":["Bioscience Asthma & Skin immunity, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience Asthma & Skin immunity, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, United States","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100338359","display_name":"Jingjing Li","orcid":"https://orcid.org/0000-0001-8000-7410","observed_orcids":["https://orcid.org/0000-0001-8000-7410"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jingjing Li","raw_affiliation_strings":["Bioscience Asthma & Skin immunity, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience Asthma & Skin immunity, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015784929","display_name":"Xavier Romero Ros","orcid":"https://orcid.org/0000-0002-5755-1693","observed_orcids":["https://orcid.org/0000-0002-5755-1693"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Xavier Romero Ros","raw_affiliation_strings":["Bioscience Asthma & Skin immunity, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience Asthma & Skin immunity, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103473467","display_name":"E. Suzanne Cohen","orcid":"https://orcid.org/0000-0002-4470-1680","observed_orcids":["https://orcid.org/0000-0002-4470-1680"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Suzanne Cohen","raw_affiliation_strings":["Bioscience Asthma & Skin immunity, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience Asthma & Skin immunity, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083313369","display_name":"Josquin A Nys","orcid":"https://orcid.org/0000-0002-6166-1588","observed_orcids":["https://orcid.org/0000-0002-6166-1588"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Josquin Nys","raw_affiliation_strings":["Bioscience Asthma & Skin immunity, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience Asthma & Skin immunity, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA1853","last_page":"PA1853"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12528","display_name":"IL-33, ST2, and ILC Pathways","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12528","display_name":"IL-33, ST2, and ILC Pathways","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-33","display_name":"IL-33","score":0.878000020980835},{"id":"https://openalex.org/keywords/precision-cut-lung-slices","display_name":"precision-cut lung slices","score":0.8809999823570251},{"id":"https://openalex.org/keywords/chronic-respiratory-disease","display_name":"chronic respiratory disease","score":0.7329999804496765},{"id":"https://openalex.org/keywords/viral-exacerbation","display_name":"viral exacerbation","score":0.7919999957084656},{"id":"https://openalex.org/keywords/inflammatory-cytokine-release","display_name":"inflammatory cytokine secretion","score":0.7480000257492065},{"id":"https://openalex.org/keywords/lipopolysaccharide-stimulation","display_name":"lipopolysaccharide stimulation","score":0.7829999923706055},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.5540000200271606},{"id":"https://openalex.org/keywords/il-5","display_name":"IL-5","score":0.9459999799728394},{"id":"https://openalex.org/keywords/drug-target-validation","display_name":"drug target validation","score":0.38499999046325684}],"concepts":[{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.6688601970672607},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5000760555267334},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.45547083020210266},{"id":"https://openalex.org/C2779278377","wikidata":"https://www.wikidata.org/wiki/Q1351647","display_name":"Rhinovirus","level":3,"score":0.4448947310447693},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.43249568343162537},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4192034602165222},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.09810766577720642},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.08754688501358032}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2023.pa1853","doi":"https://doi.org/10.1183/13993003.congress-2023.pa1853","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2023.pa1853","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway cell biology and immunopathology","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2783882736","https://openalex.org/W3081349107","https://openalex.org/W312933430","https://openalex.org/W7066527975","https://openalex.org/W3214874091","https://openalex.org/W2131548122","https://openalex.org/W7043904308","https://openalex.org/W2054599872","https://openalex.org/W3179501149","https://openalex.org/W4405183449"],"abstract_inverted_index":{"The":[0],"cytokine,":[1],"interleukin-33":[2],"(IL-33),":[3],"has":[4,228],"emerged":[5],"as":[6,129],"a":[7,47,130,220],"promising":[8,232],"therapeutic":[9],"target":[10],"in":[11,34,145,201],"chronic":[12],"respiratory":[13],"diseases":[14],"and":[15,59,66,75,84,141,165,209,225,245],"viral":[16],"exacerbations.":[17],"Despite":[18],"great":[19],"progress":[20],"being":[21],"made":[22],"with":[23,86,125,143,205,231],"simple":[24],"cell":[25],"assays,":[26],"aspects":[27],"of":[28,41,132,238],"IL-33":[29,57,98,175,197,243],"biology":[30,58,244],"require":[31],"further":[32],"investigation":[33],"complex,":[35],"translational":[36],"systems.":[37],"Consequently,":[38],"the":[39,236,239],"aim":[40],"this":[42],"work":[43],"was":[44,109,149],"to":[45,55,70,80,94,111,120,169,193,215,222,241],"develop":[46],"human":[48,121],"precision-cut":[49],"lung":[50],"slice":[51],"(huPCLS)":[52],"platform":[53,240],"suitable":[54],"explore":[56],"test":[60],"novel":[61,247],"therapies.":[62,248],"huPCLS":[63,96,100,116,182,213,227],"were":[64,78,101,117,178,183],"generated":[65],"cultured":[67],"for":[68],"up":[69],"7":[71,153],"days.":[72],"LDH":[73,134],"levels":[74,135],"H&E":[76],"staining":[77],"used":[79,110],"evaluate":[81],"tissue":[82],"viability":[83],"architecture":[85,148],"inflammatory":[87],"cytokine":[88,126],"release":[89,127,167,211],"following":[90],"LPS":[91,159],"stimulation":[92,160],"measured":[93],"assess":[95],"responsiveness.":[97],"stimulated":[99],"analysed":[102,184],"via":[103],"bulk":[104,186],"RNA-sequencing":[105],"(RNA-seq)":[106],"whilst":[107,157],"immunohistochemistry":[108],"identify":[112],"airway":[113,189],"epithelial":[114,190],"subsets.":[115],"also":[118],"exposed":[119],"rhinovirus":[122],"A":[123],"(HRV-A)":[124],"utilised":[128],"readout":[131],"infection.":[133],"peaked":[136],"1":[137],"day":[138,152,155],"post":[139],"slicing":[140],"decreased":[142],"time":[144],"culture.":[146],"Tissue":[147],"maintained":[150],"at":[151],"versus":[154],"0":[156],"24-hour":[158],"induced":[161],"significant":[162],"IL-6,":[163],"IL-1\u03b2":[164],"TNF\u03b1":[166],"relative":[168,214],"unstimulated":[170],"huPCLS.":[171,202],"In":[172,218],"pilot":[173],"studies,":[174],"responsive":[176,226],"genes":[177],"upregulated":[179],"when":[180],"IL-33-stimulated":[181],"by":[185,196,212],"RNA-seq.":[187],"Furthermore,":[188],"subsets":[191],"known":[192],"be":[194,199],"modulated":[195],"could":[198],"identified":[200],"Finally,":[203],"infection":[204],"HRV-A":[206],"increased":[207],"IFN\u03b3":[208],"IL-5":[210],"control":[216],"slices.":[217],"summary,":[219],"method":[221],"generate":[223],"viable":[224],"been":[229],"developed":[230],"initial":[233],"results":[234],"demonstrating":[235],"potential":[237],"investigate":[242],"screen":[246]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2023-10-28T00:00:00"}